Moderna | MRNA - Assets


Moderna reported $10.96B in Assets for its fiscal quarter ending in June of 2026.





Assets Change Date
Acadia Pharmaceuticals USD 1.74B 137.67M Jun/2026
Agios Pharmaceuticals USD 1.11B 76.57M Jun/2026
Alnylam Pharmaceuticals USD 5.56B 429.22M Jun/2026
Amgen USD 95.64B 3.14B Jun/2026
Arrowhead Research USD 2.11B 156.25M Jun/2026
Biogen USD 32.09B 2.6B Jun/2026
BioMarin Pharmaceutical USD 11.72B 3.13B Jun/2026
Celltrion KRW 768.81B 9.37B Mar/2026
Cspc Pharmaceutical CNY 46.7B 695.56M Dec/2025
Deva Holding AS TRY 12.93B 1.83B Sep/2023
Dianthus Therapeutics USD 1.21B 33.61M Jun/2026
Divis Laboratories Ltd INR 200.33B 18.82B Mar/2026
Gilead Sciences USD 49.36B 6.92B Jun/2026
GlaxoSmithKline GBP 61.74B 1.13B Jun/2026
Incyte USD 7.87B 533.53M Jun/2026
Ionis Pharmaceuticals USD 2.99B 455.5M Jun/2026
Kangmei Pharma CNY 13.31B 375.64M Mar/2026
Knight Therapeutics CAD 1.05B 2.28M Dec/2025
Laboratorios Farma EUR 799.88M 99.95M Dec/2023
Malin Corporation EUR 198.5M 70.1M Dec/2024
Moderna USD 10.96B 527M Jun/2026
Organigram Holdings CAD 521.31M 9.36M Mar/2026
Ovoca Bio EUR 2.07M 414K Dec/2025
Pharma Mar EUR 393.6M 8.34M Jun/2026
Puma Biotechnology USD 202.86M 7.95M Sep/2025
Qiagen NV USD 5.89B 107.14M Jun/2026
Regeneron Pharmaceuticals USD 41.73B 861.8M Jun/2026
Sangamo BioSciences USD 97.56M 11.39M Jun/2025
Sarepta Therapeutics USD 3.19B 9.58M Jun/2026
Sartorius EUR 9.6B 270.6M Jun/2026
Sino Biopharmaceutical CNY 74.89B 9.49B Jun/2025
Tilray USD 2.1B 15.95M Sep/2025
Ultragenyx Pharmaceutical USD 1.26B 32M Jun/2026
United Therapeutics USD 7.22B 505.9M Jun/2026
Vertex Pharmaceuticals USD 27.42B 938.9M Jun/2026
Zealand Pharma A/S 15.3B 647.8M Mar/2026
Zz Pientze Pharmaceu CNY 18.38B 905.93M Mar/2026